151 related articles for article (PubMed ID: 15061386)
1. In vivo total antioxidant capacity: comparison of two different analytical methods.
Vassalle C; Masini S; Carpeggiani C; L'Abbate A; Boni C; Zucchelli GC
Clin Chem Lab Med; 2004 Jan; 42(1):84-9. PubMed ID: 15061386
[TBL] [Abstract][Full Text] [Related]
2. The ferric reducing ability of plasma (FRAP) as a measure of "antioxidant power": the FRAP assay.
Benzie IF; Strain JJ
Anal Biochem; 1996 Jul; 239(1):70-6. PubMed ID: 8660627
[TBL] [Abstract][Full Text] [Related]
3. Total antioxidant capacity assay of human serum using copper(II)-neocuproine as chromogenic oxidant: the CUPRAC method.
Apak R; Güçlü K; Ozyürek M; Karademir SE; Altun M
Free Radic Res; 2005 Sep; 39(9):949-61. PubMed ID: 16087476
[TBL] [Abstract][Full Text] [Related]
4. Plasma total antioxidant capacity is associated with dietary intake and plasma level of antioxidants in postmenopausal women.
Wang Y; Yang M; Lee SG; Davis CG; Kenny A; Koo SI; Chun OK
J Nutr Biochem; 2012 Dec; 23(12):1725-31. PubMed ID: 22617460
[TBL] [Abstract][Full Text] [Related]
5. A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation.
Erel O
Clin Biochem; 2004 Apr; 37(4):277-85. PubMed ID: 15003729
[TBL] [Abstract][Full Text] [Related]
6. Cupric ion reducing antioxidant capacity assay for antioxidants in human serum and for hydroxyl radical scavengers.
Apak R; Güçlü K; Ozyürek M; Bektaşoğlu B; Bener M
Methods Mol Biol; 2010; 594():215-39. PubMed ID: 20072920
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the copper(II) reduction assay using bathocuproinedisulfonic acid disodium salt for the total antioxidant capacity assessment: the CUPRAC-BCS assay.
Campos C; Guzmán R; López-Fernández E; Casado A
Anal Biochem; 2009 Sep; 392(1):37-44. PubMed ID: 19464250
[TBL] [Abstract][Full Text] [Related]
8. Erythrocyte susceptibility to oxidative stress and antioxidant status in patients with type 1 diabetes.
Firoozrai M; Nourbakhsh M; Razzaghy-Azar M
Diabetes Res Clin Pract; 2007 Sep; 77(3):427-32. PubMed ID: 17360068
[TBL] [Abstract][Full Text] [Related]
9. Correlation of endothelin 1 plasma levels with plasma antioxidant capacity in elderly patients treated for hypertension.
Skalska AB; Pietrzycka A; Stepniewski M
Clin Biochem; 2009 Mar; 42(4-5):358-64. PubMed ID: 19046960
[TBL] [Abstract][Full Text] [Related]
10. Prooxidative/antioxidative homeostasis in heroin addiction and detoxification.
Pereska Z; Dejanova B; Bozinovska C; Petkovska L
Bratisl Lek Listy; 2007; 108(9):393-8. PubMed ID: 18225476
[TBL] [Abstract][Full Text] [Related]
11. Gender differences in antioxidant capacity of rat tissues determined by 2,2'-azinobis (3-ethylbenzothiazoline 6-sulfonate; ABTS) and ferric reducing antioxidant power (FRAP) assays.
Katalinic V; Modun D; Music I; Boban M
Comp Biochem Physiol C Toxicol Pharmacol; 2005 Jan; 140(1):47-52. PubMed ID: 15792622
[TBL] [Abstract][Full Text] [Related]
12. Measurement of total antioxidant capacity of human plasma: setting and validation of the CUPRAC-BCS method on routine apparatus ADVIA 2400.
Gosmaro F; Bagnati M; Berto S; Bellomo G; Prenesti E
Talanta; 2013 Oct; 115():526-32. PubMed ID: 24054628
[TBL] [Abstract][Full Text] [Related]
13. Comparative evaluation of Fe(III) reducing power-based antioxidant capacity assays in the presence of phenanthroline, batho-phenanthroline, tripyridyltriazine (FRAP), and ferricyanide reagents.
Berker KI; Güçlü K; Tor I; Apak R
Talanta; 2007 May; 72(3):1157-65. PubMed ID: 19071739
[TBL] [Abstract][Full Text] [Related]
14. Ferric reducing ability of plasma and assessment of selected plasma antioxidants in adults with celiac disease.
Piątek-Guziewicz A; Zagrodzki P; Paśko P; Krośniak M; Mach T; Zwolińska-Wcisło M
Folia Med Cracov; 2017; 57(4):13-26. PubMed ID: 29337974
[TBL] [Abstract][Full Text] [Related]
15. Determination of nitrite plus nitrate and malondialdehyde in human plasma: analytical performance and the effect of smoking and exercise.
Vassalle C; Lubrano V; L'Abbate A; Clerico A
Clin Chem Lab Med; 2002 Aug; 40(8):802-9. PubMed ID: 12392309
[TBL] [Abstract][Full Text] [Related]
16. Determination of antioxidant capacities of vegetable oils by ferric-ion spectrophotometric methods.
Szydłowska-Czerniak A; Dianoczki C; Recseg K; Karlovits G; Szłyk E
Talanta; 2008 Aug; 76(4):899-905. PubMed ID: 18656676
[TBL] [Abstract][Full Text] [Related]
17. Spectrophotometric assays for total antioxidant capacity (TAC) in dog serum: an update.
Rubio CP; Hernández-Ruiz J; Martinez-Subiela S; Tvarijonaviciute A; Ceron JJ
BMC Vet Res; 2016 Aug; 12(1):166. PubMed ID: 27526688
[TBL] [Abstract][Full Text] [Related]
18. Antioxidant status and oxidative stress in primary open angle glaucoma and pseudoexfoliative glaucoma.
Erdurmuş M; Yağcı R; Atış Ö; Karadağ R; Akbaş A; Hepşen IF
Curr Eye Res; 2011 Aug; 36(8):713-8. PubMed ID: 21780920
[TBL] [Abstract][Full Text] [Related]
19. Ferric reducing ability of tears in healthy subjects-diurnal variation and dependence on defined demographic data.
Kowalski M; Bielecka-Kowalska A; Bielecka-Roszkiewicz K; Dziankowska-Zaborszczyk E; de Graft-Johnson J; Szemraj J; Zwolinska A; Nowak D
Curr Eye Res; 2009 May; 34(5):333-9. PubMed ID: 19401875
[TBL] [Abstract][Full Text] [Related]
20. Measuring the antioxidant capacity of blood plasma using potentiometry.
Tessutti LS; Macedo DV; Kubota LT; Alves AA
Anal Biochem; 2013 Oct; 441(2):109-14. PubMed ID: 23872008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
